Coronavirus | Delhi HC anguished over shortage of vaccines in India
The Hindu
The high court directed the Centre to release arbitral award of over ₹14 crore along with interest from 2012 to Panacea Biotec for manufacturing Sputnik V vaccine in India.
The Delhi High Court on Friday expressed anguish over the way things have transpired in the second wave of COVID-19 where vaccine shortage is hitting everyone even when the Central government says the best way to fight the pandemic is to vaccinate the entire population. The high court was deliberating with the issue related to manufacturing of COVID vaccine Sputnik V by India's Panacea Biotec in collaboration with Russian Direct Investment Fund (RDIF).More Related News
The event will run daily from 10 a.m. to 8.30 p.m., offering a variety of activities. Visitors can enjoy dance and music performances, hands-on art experiences, film screenings, and exhibitions from 10.30 a.m. to 6.30 p.m. These will feature folk cuisines, leather puppets, philately, textiles, and handicrafts.